Development of the PARP inhibitor talazoparib for the treatment of advanced BRCA1 and BRCA2 mutated breast cancer
- Evthokia A. Hobbs
- , Jennifer K. Litton
- , Timothy A. Yap
Research output: Contribution to journal › Article › peer-review
35
!!Link opens in a new tab
Scopus
citations